Caxton Associates (New York)’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-17,386
| Closed | -$55K | – | 674 |
|
|
2022
Q1 | $55K | Hold |
17,386
| – | – | ﹤0.01% | 456 |
|
|
2021
Q4 | $56K | Hold |
17,386
| – | – | 0.01% | 512 |
|
|
2021
Q3 | $58K | Hold |
17,386
| – | – | 0.01% | 407 |
|
|
2021
Q2 | $68K | Hold |
17,386
| – | – | 0.01% | 432 |
|
|
2021
Q1 | $70K | Buy |
+17,386
| New | +$70K | 0.01% | 382 |
|